Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial.
about
HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsNovel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccinesNew prospects for a preventive HIV-1 vaccine.Conditional Immune Escape during Chronic Simian Immunodeficiency Virus InfectionIncreased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance.Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.Polyvalent vaccine approaches to combat HIV-1 diversityLong-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice.HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells.A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.Role of HIV-specific CD8(+) T cells in pediatric HIV cure strategies after widespread early viral escape.Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo.Development of novel vaccine vectors: Chimpanzee adenoviral vectors.Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.Simian adenoviruses as vaccine vectors.Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B
P2860
Q27687375-0FDA7D7F-76EE-48B6-BDF6-0BF9570F4373Q28079455-C7B31185-4AB8-49E8-97B7-A486D28B2B38Q33610621-1342F852-66AE-4FC2-A250-82037A6B680CQ36223864-9BEBC03D-B743-47BC-91AD-6A31BA88628EQ36433848-D16B5738-8A6B-4FE5-B041-02FE6D41FE3BQ36756865-5C4CD07C-CA7E-443D-8B43-D8EED60DDDF9Q36845154-2FFFA84A-4A90-466F-A5B5-09798FA423C0Q37221660-D0D73D19-833A-449F-8F8A-7C74230495AFQ39108740-36FD7ED6-D81F-44B7-8C7D-E3F450F582DFQ40118193-F1C5B69B-5E53-4597-B376-843FEECC94D1Q40210139-0505E843-266D-46EC-8601-212D1FDC910DQ40348395-65681FFE-88B7-41F3-A645-FB0B6C56E71FQ40548641-BED42081-7CC4-4B2F-8104-9617EE5B3B86Q41923263-200A9026-EEAE-43F1-A385-E37C02C451C9Q47549105-8A5E4B71-C96F-4FFD-AB3F-18DE6860B767Q47558190-2AA88CA1-3E00-413A-8561-C0DB04505EB8Q47607706-AAABB619-F68C-4CBB-88BD-E3E31A4015B6Q54531277-70DF8671-E980-48EE-BC7E-9C1572C65C17Q55177142-0ED7BE60-9AB2-4DC3-86CC-4631F47767A5Q57009763-25DD97CA-E86B-44B6-923E-6B88CEFE65F7
P2860
Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Safety and tolerability of con ...... d, single-blind phase I trial.
@ast
Safety and tolerability of con ...... d, single-blind phase I trial.
@en
type
label
Safety and tolerability of con ...... d, single-blind phase I trial.
@ast
Safety and tolerability of con ...... d, single-blind phase I trial.
@en
prefLabel
Safety and tolerability of con ...... d, single-blind phase I trial.
@ast
Safety and tolerability of con ...... d, single-blind phase I trial.
@en
P2093
P2860
P921
P1433
P1476
Safety and tolerability of con ...... ed, single-blind phase I trial
@en
P2093
Alison Crook
Annie Rose
Antony P Black
Emma-Jo Hayton
Lucy Dorrell
Mariarosaria Del Sorbo
Tomáš Hanke
Umar Ibrahimsa
P2860
P304
P356
10.1371/JOURNAL.PONE.0101591
P407
P577
2014-07-09T00:00:00Z